Source:http://linkedlifedata.com/resource/pubmed/id/17054930
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
2006-12-12
|
| pubmed:abstractText |
Therapeutic monitoring of everolimus with chromatographic methods (HPLC) enabled effective immunosuppression while limiting the incidence of drug-related adverse events. A fluorescence polarization immunoassay (FPIA) has been recently developed for the assessment of everolimus levels. The present study was designed to evaluate FPIA performance and to compare it to HPLC.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0009-9120
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
39
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1152-9
|
| pubmed:meshHeading |
pubmed-meshheading:17054930-Chromatography, High Pressure Liquid,
pubmed-meshheading:17054930-Cross Reactions,
pubmed-meshheading:17054930-Fluorescence Polarization Immunoassay,
pubmed-meshheading:17054930-Heart Transplantation,
pubmed-meshheading:17054930-Reagent Kits, Diagnostic,
pubmed-meshheading:17054930-Sirolimus,
pubmed-meshheading:17054930-Ultraviolet Rays
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation.
|
| pubmed:affiliation |
Department of Medicine and Transplantation, Ospedali Riuniti di Bergamo-Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|